Manufacturing economics of plant-made biologics: Case studies in therapeutic and industrial enzymes

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Tusé, Daniel ^a   Tu, Tiffany ^b   McDonald, Karen A ^b  

^a Intrucept Biomedicine LLC   (United States)

^b University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULASE; CHOLINESTERASE; INDUSTRIAL ENZYME; BIOFUEL; BIOLOGICAL PRODUCT; RECOMBINANT PROTEIN;

AGROBACTERIUM; ARTICLE; COST; ECONOMICS; ENZYME PURIFICATION; ENZYME SYNTHESIS; FERMENTATION; GENE EXPRESSION; GLYCOSYLATION; HYPOCREA JECORINA; NICOTIANA; NICOTIANA BENTHAMIANA; PLANT GROWTH; PROTEIN PROCESSING; TRANSGENIC PLANT; BIOSYNTHESIS; BIOTECHNOLOGY; CHEMISTRY; COMPUTER PROGRAM; COMPUTER SIMULATION; COST BENEFIT ANALYSIS; GENE EXPRESSION REGULATION; METABOLISM; PLANT; TOBACCO;

BIOFUELS; BIOLOGICAL PRODUCTS; BIOTECHNOLOGY; BUTYRYLCHOLINESTERASE; CELLULASE; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; GENE EXPRESSION REGULATION; PLANTS; RECOMBINANT PROTEINS; SOFTWARE; TOBACCO;

EID: 84902176028     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/256135     Document Type: Article

References (51)

1. Thomas D. R., Penney C. A., Majumder A., Walmsley A. M., Evolution of plant-made pharmaceuticals. International Journal of Molecular Sciences 2011 12 5 3220 3236 2-s2.0-79957822647 10.3390/ijms12053220
2. Pogue G. P., Vojdani F., Palmer K. E., Hiatt E., Hume S., Phelps J., Long L., Bohorova N., Kim D., Pauly M., Velasco J., Whaley K., Zeitlin L., Garger S. J., White E., Bai Y., Haydon H., Bratcher B., Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems. Plant Biotechnology Journal 2010 8 5 638 654 2-s2.0-77953980755 10.1111/j.1467-7652.2009.00495.x
3. Komarova T. V., Baschieri S., Donini M., Marusic C., Benvenuto E., Dorokhov Y. L., Transient expression systems for plant-derived biopharmaceuticals. Expert Review of Vaccines 2010 9 8 859 876 2-s2.0-77955260676 10.1586/erv.10.85
4. Klimyuk V., Herz S., Butler J., Haydon H., Production of recombinant antigens and antibodies in Nicotiana benthamiana Using "Magnifection" technology: GMP-compliant facilities for small- and large-scale manufacturing. Current Topics in Microbiology and Immunology 2014 375 127 154
5. Gleba Y. Y., Tusé D., Giritch A., Plant viral vectors for delivery by agrobacterium. Current Topics in Microbiology and Immunology 2014 375 155 192
6. Giritch A., Marillonnet S., Engler C., van Eldik G., Botterman J., Klimyuk V., Gleba Y., Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectros. Proceedings of the National Academy of Sciences of the United States of America 2006 103 40 14701 14706 2-s2.0-33749536223 10.1073/pnas.0606631103 (Pubitemid 44527793)
7. Werner S., Breus O., Symonenko Y., Marillonnet S., Gleba Y., High-level recombinant protein expression in transgenic plants by using a double-inducible viral vector. Proceedings of the National Academy of Sciences of the United States of America 2011 108 34 14061 14066 2-s2.0-80052146674 10.1073/pnas.1102928108
8. Davies H. M., Commercialization of whole-plant systems for biomanufacturing of protein products: evolution and prospects. Plant Biotechnology Journal 2010 8 8 845 861 2-s2.0-77956440770 10.1111/j.1467-7652. 2010.00550.x
9. Elbehri A., Biopharming and the food system: Examining the potential benefits and risks. AgBioForum 2005 8 1 18 25 2-s2.0-21644475978 (Pubitemid 40935684)
10. Farid S. S., Process economics of industrial monoclonal antibody manufacture. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 2007 848 1 8 18 2-s2.0-33847613926 10.1016/j.jchromb.2006.07.037 (Pubitemid 46367764)
11. Hood E. E., Woodard S. L., Horn M. E., Monoclonal antibody manufacturing in transgenic plants: myths and realities. Current Opinion in Biotechnology 2002 13 6 630 635 2-s2.0-0036901079 10.1016/S0958-1669(02)00351-8 (Pubitemid 35448068)
12. Kaiser J., Is the drought over for pharming. Science 2008 320 5875 473 475 2-s2.0-42549170120 10.1126/science.320.5875.473 (Pubitemid 351590625)
13. Ma J. K.-C., Chikwamba R., Sparrow P., Fischer R., Mahoney R., Twyman R. M., Plant-derived pharmaceuticals: the road forward. Trends in Plant Science 2005 10 12 580 585 2-s2.0-28244473326 10.1016/j.tplants.2005.10.009 (Pubitemid 41714013)
14. Evangelista R. L., Kusnadi A. R., Howard J. A., Nikolov Z. L., Process and economic evaluation of the extraction and purification of recombinant β -glucuronidase from transgenic corn. Biotechnology Progress 1998 14 4 607 614 2-s2.0-0032127253 10.1021/bp980047c (Pubitemid 28382654)
15. Nandi S., Yalda D., Lu S., Nikolov Z., Misaki R., Fujiyama K., Huang N., Process development and economic evaluation of recombinant human lactoferrin expressed in rice grain. Transgenic Research 2005 14 3 237 249 2-s2.0-22144487779 10.1007/s11248-004-8120-6 (Pubitemid 40982710)
16. Klein-Marcuschamer D., Oleskowicz-Popiel P., Simmons B. A., Blanch H. W., The challenge of enzyme cost in the production of lignocellulosic biofuels. Biotechnology and Bioengineering 2012 109 4 1083 1087 2-s2.0-84857441283 10.1002/bit.24370
17. Ernst S., Garro O. A., Winkler S., Venkataraman G., Langer R., Cooney C. L., Sasisekharan R., Process simulation for recombinant protein production: cost estimation and sensitivity analysis for heparinase I expressed in Escherichia coli. Biotechnology and Bioengineering 1997 53 6 575 582 (Pubitemid 27114320)
18. Zapalac E., McDonald K., Heinzle E., Biwer A. P., Cooney C. L., Alpha-1-antitrypsin from transgenic plant cell suspension cultures. Development of SustaInable Bioprocesses 2007 261 270
19. Pogue G. P., Lindbo J. A., Garger S. J., Fitzmaurice W. P., Making an ally from an enemy: plant virology and the new agriculture. Annual Review of Phytopathology 2002 40 45 74 2-s2.0-0036031563 10.1146/annurev.phyto.40.021102. 150133 (Pubitemid 35235575)
20. De Muynck B., Navarre C., Boutry M., Production of antibodies in plants: status after twenty years. Plant Biotechnology Journal 2010 8 5 529 563 2-s2.0-77953999126 10.1111/j.1467-7652.2009.00494.x
21. Streatfield S. J., Howard J. A., Plant-based vaccines. International Journal for Parasitology 2003 33 5-6 479 493 2-s2.0-0038024485 10.1016/S0020-7519(03)00052-3 (Pubitemid 36638531)
22. McCormick A. A., Reddy S., Reinl S. J., Cameron T. I., Czerwinkski D. K., Vojdani F., Hanley K. M., Garger S. J., White E. L., Novak J., Barrett J., Holtz R. B., Tusé D., Levy R., Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study. Proceedings of the National Academy of Sciences of the United States of America 2008 105 29 10131 10136 2-s2.0-48249120731 10.1073/pnas.0803636105
23. Bendandi M., Marillonnet S., Kandzia R., Thieme F., Nickstadt A., Herz S., Fröde R., Inogés S., Lòpez-Dìaz de Cerio A., Soria E., Villanueva H., Vancanneyt G., McCormick A., Tusé D., Lenz J., Butler-Ransohoff J.-E., Klimyuk V., Gleba Y., Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma. Annals of Oncology 2010 21 12 2420 2427 2-s2.0-77950383145 10.1093/annonc/mdq256
24. Tusé D., Safety of plant-made pharmaceuticals: product development and regulatory considerations based on case studies of two autologous human cancer vaccines. Human Vaccines 2011 7 3 322 330 2-s2.0-79953712649 10.4161/hv.7.3.14213
25. Lockridge O., Bartels C. F., Vaughan T. A., Complete amino acid sequence of human serum cholinesterase. Journal of Biological Chemistry 1987 262 2 549 557 2-s2.0-0023118832 (Pubitemid 17005217)
26. Ostergaard D., Viby-Mogensen J., Hanel H. K., Skovgaard L. T., Half-life of plasma cholinesterase. Acta Anaesthesiologica Scandinavica 1988 32 3 266 269 2-s2.0-0023896199 (Pubitemid 18098974)
27. Magill A. J., DARPA Proposers' Day: Butyrylcholinesterase Expression in Plants. 2012
28. Lockridge O., Schopfer L. M., Winger G., Woods J. H., Large scale purification of butyrylcholinesterase from human plasma suitable for injection into monkeys, a potential new therapeutic for protection against cocaine and nerve agent toxicity. Journal of Medical, Chemical, Biological, and Radiological Defense 2005 3 nihms5095
29. Geyer B. C., Kannan L., Garnaud P.-E., Broomfield C. A., Cadieux C. L., Cherni I., Hodgins S. M., Kasten S. A., Kelley K., Kilbourne J., Oliver Z. P., Otto T. C., Puffenberger I., Reeves T. E., Robbins N. II, Woods R. R., Soreq H., Lenz D. E., Cerasoli D. M., Mor T. S., Plant-derived human butyrylcholinesterase, but not an organophosphorous-compound hydrolyzing variant thereof, protects rodents against nerve agents. Proceedings of the National Academy of Sciences of the United States of America 2010 107 47 20251 20256 2-s2.0-78650558595 10.1073/pnas.1009021107
30. Masson P., Shafferman A., Velan B., Expression and refolding of functional human butyrylcholinesterase from E. Coli. Multidisciplinary Approaches To Cholinesterase Functions 1992 New York, NY, USA Plenum 49 52
31. Altamirano C. V., Lockridge O., Association of tetramers of human butyrylcholinesterase is mediated by conserved aromatic residues of the carboxy terminus. Chemico-Biological Interactions 1999 119-120 53 60 2-s2.0-18744437671 10.1016/S0009-2797(99)00013-7 (Pubitemid 29278538)
32. Millard C. B., Design and expression of organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase. Biochemistry 1995 34 49 15925 15933 2-s2.0-0028788139
33. Huang Y.-J., Huang Y., Baldassarre H., Wang B., Lazaris A., Leduc M., Bilodeau A. S., Bellemare A., Côté M., Herskovits P., Touati M., Turcotte C., Valeanu L., Lemée N., Wilgus H., Bégin I., Bhatia B., Rao K., Neveu N., Brochu E., Pierson J., Hockley D. K., Cerasoli D. M., Lenz D. E., Karatzas C. N., Langermann S., Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning. Proceedings of the National Academy of Sciences of the United States of America 2007 104 34 13603 13608 2-s2.0-35348893697 10.1073/pnas.0702756104 (Pubitemid 350010655)
34. Hayward R. L., Production of Recombinant Human Butyrylcholinesterase in Nicotiana benthamiana [Master of Science] 2012 The University of Guelph
35. Mor T., Kannan L., Larrimore K. E., Compositions and methods for the production and use of human cholinesterases. Patent Application 2012 WO 2013040572 A2
36. Schneider J. D., Castilho A., Neumann L., Altmann F., Loos A., Kannan L., Mor T. S., Steinkellner H., Expression of human butyrylcholinesterase with an engineered glycosylation profile resembling the plasma-derived orthologue. Biotechnology Journal 2013 10.1002/biot.201300229
37. DARPA, DARPA Broad Agency Announcement: Butyrylcholinesterase Expression in Plants. 2012
38. Marillonnet S., Thoeringer C., Kandzia R., Klimyuk V., Gleba Y., Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants. Nature Biotechnology 2005 23 6 718 723 2-s2.0-24944498904 10.1038/nbt1094 (Pubitemid 41716362)
39. Gleba Y. Y., Giritch A., Altman A., Hasegawa P. M., Vaccines, antibodies, and pharmaceutical proteins. Plant Biotechnology and Agriculture: Prospects For the 21st Century 2012 Elsevier 465 479
40. Burkle R., Chew C., Li C., 'Brien K. O., Paridon K., Tu T., Wang J., McDonald K., Large-scale biomanufacturing facility for production of an antidote against sarin and other nerve agents. Proceedings of the AICHE Annual Meeting 2013
41. Sainz M. B., Dale J., Towards cellulosic ethanol from sugarcane bagasse. Proceedings of the Australian Society of Sugar Cane Technology 2009 31 18 23
42. Sainz M. B., Commercial cellulosic ethanol: The role of plant-expressed enzymes. In Vitro Cellular and Developmental Biology: Plant 2009 45 3 314 329 2-s2.0-68649119757 10.1007/s11627-009-9210-1
43. Hahn S., Giritch A., Gleba Y., Production, storage and use of cell wall-degrading enzymes. Patent Application 2013 EP2584042A1
44. Mundell R., Chambers O., O'Daniel J. P., Davies H. M., Evaluation of float trays with high cell numbers on stand counts and yields in a close-grown tobacco production system. Tobacco Science 2012 49 4 7
45. Seebold K., 2013-2014 Kentucky and Tennessee Tobacco Production Guide 2013
46. Sheen S. J., Biomass and chemical composition of tobacco plants under high density growth. Beiträge Zur Tabakforschung International 1983 12 1 35 42
47. Chang C. S., Hurng W. P., Hu H. Y., Chen L. H., Wu D. K., The yield of biomass and leaf protein of tobacco plants grown at high density with multiple harvest. I. Experiments on plant density. Bulletin of Taiwan Tobacco Research Institute, Taiwan Tobacco and Wine Monopoly Bureau 1990 32 1 7
48. Scott G. L., Warren J. F., Tobacco production system. Patent Application 2013 WO2013028539 A2
49. Humbird D., Davis R., Tao L., Process design and economics for biochemical conversion of lignocellulosic biomass to ethanol: dilute-acid pretreatment and enzymatic hydrolysis of corn Stover. 2011 NREL/TP-5100-47764. http://www.nrel.gov/biomass/pdfs/47764.pdf
50. Castilho A., Gattinger P., Grass J., Jez J., Pabst M., Altmann F., Gorfer M., Strasser R., Steinkellner H., N-Glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans. Glycobiology 2011 21 6 813 823 2-s2.0-79956093771 10.1093/glycob/cwr009
51. Zeitlin L., Pettitt J., Scully C., Bohorova N., Kim D., Pauly M., Hiatt A., Ngo L., Steinkellner H., Whaley K. J., Olinger G. G., Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant. Proceedings of the National Academy of Sciences of the United States of America 2011 108 51 20690 20694 2-s2.0-84855492921 10.1073/pnas.1108360108